454 related articles for article (PubMed ID: 33931980)
1. The function of LncRNAs and their role in the prediction, diagnosis, and prognosis of lung cancer.
Chen Y; Zitello E; Guo R; Deng Y
Clin Transl Med; 2021 Apr; 11(4):e367. PubMed ID: 33931980
[TBL] [Abstract][Full Text] [Related]
2. [Lung cancer screening in high-risk subjects: early detection with LDCT and risk stratification using miRNA-based blood test].
Sestini S; Boeri M; Marchianò A; Silva M; Calareso G; Galeone C; Sozzi G; Pastorino U
Epidemiol Prev; 2016; 40(1 Suppl 1):42-50. PubMed ID: 26951732
[TBL] [Abstract][Full Text] [Related]
3. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
4. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer.
Tao Y; Tang Y; Yang Z; Wu F; Wang L; Yang L; Lei L; Jing Y; Jiang X; Jin H; Bai Y; Zhang L
Int J Biol Sci; 2020; 16(3):471-482. PubMed ID: 32015683
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
Ricciuti B; Mencaroni C; Paglialunga L; Paciullo F; Crinò L; Chiari R; Metro G
Med Oncol; 2016 Feb; 33(2):18. PubMed ID: 26786153
[TBL] [Abstract][Full Text] [Related]
6. Blood-based liquid biopsy: Insights into early detection and clinical management of lung cancer.
Liu C; Xiang X; Han S; Lim HY; Li L; Zhang X; Ma Z; Yang L; Guo S; Soo R; Ren B; Wang L; Goh BC
Cancer Lett; 2022 Jan; 524():91-102. PubMed ID: 34656690
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
Sestini S; Boeri M; Marchiano A; Pelosi G; Galeone C; Verri C; Suatoni P; Sverzellati N; La Vecchia C; Sozzi G; Pastorino U
Oncotarget; 2015 Oct; 6(32):32868-77. PubMed ID: 26451608
[TBL] [Abstract][Full Text] [Related]
8. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer.
Tantai J; Hu D; Yang Y; Geng J
Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353
[TBL] [Abstract][Full Text] [Related]
9. Circulating plasma lncRNAs as novel markers of EGFR mutation status and monitors of epidermal growth factor receptor-tyrosine kinase inhibitor therapy.
Lv P; Yang S; Liu W; Qin H; Tang X; Wu F; Liu Z; Gao H; Liu X
Thorac Cancer; 2020 Jan; 11(1):29-40. PubMed ID: 31691525
[TBL] [Abstract][Full Text] [Related]
10. Radiation burden and associated cancer risk for a typical population to be screened for lung cancer with low-dose CT: A phantom study.
Perisinakis K; Seimenis I; Tzedakis A; Karantanas A; Damilakis J
Eur Radiol; 2018 Oct; 28(10):4370-4378. PubMed ID: 29651767
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.
Sozzi G; Boeri M; Rossi M; Verri C; Suatoni P; Bravi F; Roz L; Conte D; Grassi M; Sverzellati N; Marchiano A; Negri E; La Vecchia C; Pastorino U
J Clin Oncol; 2014 Mar; 32(8):768-73. PubMed ID: 24419137
[TBL] [Abstract][Full Text] [Related]
12. Research progress regarding long-chain non-coding RNA in lung cancer: a narrative review.
Yu P; He X; Lu F; Li L; Song H; Bian X
J Thorac Dis; 2022 Aug; 14(8):3016-3029. PubMed ID: 36071788
[TBL] [Abstract][Full Text] [Related]
13. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
[TBL] [Abstract][Full Text] [Related]
14. Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study.
Wei MN; Su Z; Wang JN; Gonzalez Mendez MJ; Yu XY; Liang H; Zhou QH; Fan YG; Qiao YL
Thorac Cancer; 2020 May; 11(5):1224-1232. PubMed ID: 32196998
[TBL] [Abstract][Full Text] [Related]
15. Identification of long noncoding RNAs for the detection of early stage lung squamous cell carcinoma by microarray analysis.
Cheng Z; Bai Y; Wang P; Wu Z; Zhou L; Zhong M; Jin Q; Zhao J; Mao H; Mao H
Oncotarget; 2017 Feb; 8(8):13329-13337. PubMed ID: 28076325
[TBL] [Abstract][Full Text] [Related]
16. Radiation risks in lung cancer screening programs: a comparison with nuclear industry workers and atomic bomb survivors.
McCunney RJ; Li J
Chest; 2014 Mar; 145(3):618-24. PubMed ID: 24590022
[TBL] [Abstract][Full Text] [Related]
17. The plasma lncRNA acting as fingerprint in non-small-cell lung cancer.
Hu X; Bao J; Wang Z; Zhang Z; Gu P; Tao F; Cui D; Jiang W
Tumour Biol; 2016 Mar; 37(3):3497-504. PubMed ID: 26453113
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer.
Peng W; Wang J; Shan B; Peng Z; Dong Y; Shi W; He D; Cheng Y; Zhao W; Zhang C; Li B; Duan C
Cell Physiol Biochem; 2018; 49(2):816-827. PubMed ID: 30165346
[TBL] [Abstract][Full Text] [Related]
19. A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT).
Wang X; Zhi X; Yang Z; Tian H; Li Y; Li M; Zhao W; Zhang C; Wang T; Liu J; Shen D; Zheng C; Zhao D; Yang S; Qi J; Xin H; Stojadinovic A; Avital I; Lee LJ; Rao J; Zhang W
Oncotarget; 2017 Jul; 8(28):45345-45355. PubMed ID: 28514755
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
